The molecular prognostic score, a classifier for risk stratification of high-grade serous ovarian cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
The molecular prognostic score, a classifier for risk stratification of high-grade serous ovarian cancer ; volume:17 ; number:1 ; day:2 ; month:8 ; year:2024 ; pages:1-14 ; date:12.2024
Journal of ovarian research ; 17, Heft 1 (2.8.2024), 1-14, 12.2024
- Creator
-
Sarkar, Siddik
Saha, Sarbar Ali
Swarnakar, Abhishek
Chakrabarty, Arnab
Dey, Avipsa
Sarkar, Poulomi
Banerjee, Sarthak
Mitra, Pralay
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13048-024-01482-5
- URN
-
urn:nbn:de:101:1-2411010747246.464071147291
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sarkar, Siddik
- Saha, Sarbar Ali
- Swarnakar, Abhishek
- Chakrabarty, Arnab
- Dey, Avipsa
- Sarkar, Poulomi
- Banerjee, Sarthak
- Mitra, Pralay
- SpringerLink (Online service)
Other Objects (12)
ClassifieR 2.0: expanding interactive gene expression-based stratification to prostate and high-grade serous ovarian cancer
Multimodal data integration using machine learning improves risk stratification of high-grade serous ovarian cancer
High-grade serous ovarian cancer: the clone wars
Histopathologic image–based deep learning classifier for predicting platinum-based treatment responses in high-grade serous ovarian cancer
First-Line Management of Advanced High-Grade Serous Ovarian Cancer
PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer
Tumor Evolution and Heterogeneity in High-Grade Serous Ovarian Cancer
Principles of dormancy evident in high-grade serous ovarian cancer
MRI for differentiating ovarian endometrioid adenocarcinoma from high-grade serous adenocarcinoma
No evidence for PALB2 methylation in high-grade serous ovarian cancer
Biological and prognostic value of ETV5 in high-grade serous ovarian cancer
Comparative analysis of syngeneic mouse models of high-grade serous ovarian cancer
ClassifieR 2.0: expanding interactive gene expression-based stratification to prostate and high-grade serous ovarian cancer
Multimodal data integration using machine learning improves risk stratification of high-grade serous ovarian cancer
High-grade serous ovarian cancer: the clone wars
Histopathologic image–based deep learning classifier for predicting platinum-based treatment responses in high-grade serous ovarian cancer
First-Line Management of Advanced High-Grade Serous Ovarian Cancer
PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer
Tumor Evolution and Heterogeneity in High-Grade Serous Ovarian Cancer
Principles of dormancy evident in high-grade serous ovarian cancer
MRI for differentiating ovarian endometrioid adenocarcinoma from high-grade serous adenocarcinoma
No evidence for PALB2 methylation in high-grade serous ovarian cancer
Biological and prognostic value of ETV5 in high-grade serous ovarian cancer
Comparative analysis of syngeneic mouse models of high-grade serous ovarian cancer
ClassifieR 2.0: expanding interactive gene expression-based stratification to prostate and high-grade serous ovarian cancer
Multimodal data integration using machine learning improves risk stratification of high-grade serous ovarian cancer
High-grade serous ovarian cancer: the clone wars
Histopathologic image–based deep learning classifier for predicting platinum-based treatment responses in high-grade serous ovarian cancer
First-Line Management of Advanced High-Grade Serous Ovarian Cancer
PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer
Tumor Evolution and Heterogeneity in High-Grade Serous Ovarian Cancer
Principles of dormancy evident in high-grade serous ovarian cancer
MRI for differentiating ovarian endometrioid adenocarcinoma from high-grade serous adenocarcinoma
No evidence for PALB2 methylation in high-grade serous ovarian cancer
Biological and prognostic value of ETV5 in high-grade serous ovarian cancer